Novo Nordisk said it would begin selling its Type 2 diabetes treatment Ozempic directly to consumers at $499 per month, half the U.S. list price of the medicine.

The Dow closes flat, and S&P 500 and Nasdaq fall Tuesday as the stock market weighed retail earnings and Trump's Ukraine meeting.

Berkshire Hathaway’s latest 13F filing revealed a new position in D.R. Horton stock in the second quarter.

The message in the Nvidia revenue-sharing plan is that everything is negotiable, Christopher Tang writes in a guest commentary.

About the author: Julia Graf is a former finance professional at Bank of America, State Street, and Fidelity. She now advises on energy, industrial strategy, and artificial intelligence ...

President Donald Trump’s unstoppable force of will is likely to triumph over Federal Reserve Chairman Jerome Powell’s immovable object of caution when it comes to lower interest rates.

Tesla stock is rising. The Elon Musk-led EV maker is looking for robo-taxi testers for New York City. It shows how the company plans to expand its self-driving cab business in the coming months.

Amid pressure from the White House, U.S. drug companies are experimenting with direct-to-consumer sales models that cut out the middlemen.

The inventor of the “4% rule” has revised his math. What to know about giving yourself a pay hike.

Investors might want to consider Tesla CEO Eon Musk’s tweets about self-driving technology from the weekend.

Eli Lilly CEO David Ricks bought just over $1 million of Lilly shares in the open market Tuesday following the sharp drop in the stock in the wake of its second-quarter earnings report last week.

The stock market is at record high and is getting a boost from rate cut bets. That might not be good news.